Skip to main content
Invivyd, Inc. logo

Invivyd, Inc. — Investor Relations & Filings

Ticker · IVVD ISIN · US00534A1025 US Manufacturing
Open in API
Filings indexed 404 across all filing types
Latest filing 2026-05-19 Declaration of Voting R…
Country US United States of America
Listing US IVVD

About Invivyd, Inc.

https://invivyd.com/

Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for serious viral infectious diseases. The company's mission is to rapidly and continually deliver therapies that keep pace with evolving viral threats. Utilizing a proprietary technology platform, Invivyd develops monoclonal antibody candidates designed to be more potent and resistant to virus evolution than the human immune system. Its pipeline is initially focused on addressing SARS-CoV-2, with plans to expand into other high-need indications such as influenza.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an SEC Form 8-K (Current Report) containing Item 5.07 “Submission of Matters to a Vote of Security Holders” with detailed vote tallies from the company’s Annual Meeting. It reports the final voting results certified by the inspector of election. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-19 English
S-8
Share Issue/Capital Change Classification · 85% confidence The document is a U.S. SEC Form S-8 "Registration Statement Under the Securities Act of 1933" for registering additional shares under employee equity plans, ESPP, and an inducement plan. It is not a financial results announcement, proxy, or general corporate governance disclosure—it specifically registers new share issuances under stock plans (a capital change). Therefore it best fits the “Share Issue/Capital Change” category (SHA).
2026-05-14 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-14 English
8-K
Regulatory Filings
2026-05-14 English
8-K - Invivyd, Inc. (0001832038) (Filer)
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 9, 2026. It announces other events including a press release about the company's program progress and an updated corporate presentation posted on the company's website. The document includes references to exhibits containing the press release and the corporate presentation. The text does not contain detailed financial statements or substantive financial data, but rather announcements of events and materials. The document length is 3373 characters, which is relatively short and consistent with an announcement rather than a full report. The presence of a corporate presentation as an exhibit and the nature of the content indicate this is an Investor Presentation update filed as part of a current report. Therefore, the most appropriate classification is Investor Presentation (IP).
2026-04-09 English
ARS - Invivyd, Inc. (0001832038) (Filer)
Annual Report
2026-04-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.